Ryman Healthcare Ltd.

Ryman Healthcare Ltd.'s next confirmed earnings release is scheduled for November 25, 2026.

As of March 31, 2025, Ryman Healthcare Ltd. has 1.02B shares outstanding.

As of March 31, 2025, Ryman Healthcare Ltd. maintains a current ratio of 0.24, meaning it holds 0.2x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 39.78, indicating elevated leverage, while an interest coverage ratio of -1.74 demonstrates limited ability to service its debt obligations.

Over the twelve months ended March 31, 2025, Ryman Healthcare Ltd. posted a negative return on equity (ROE) of -10.07, meaning shareholder capital produced losses rather than profits. Return on assets (ROA) is negative at -3.47, reflecting losses generated across the asset base. The company generates approximately 83,200.21 in revenue per employee across its workforce of 7,800.00, a quick read on workforce productivity versus industry peers.

Over the twelve months ended March 31, 2025, Ryman Healthcare Ltd. recorded 201.33M in income tax expense. The company reported a pretax loss of -195.82M and -397.15M in bottom-line net income, so the effective tax rate carries little signal until profitability returns.

As of the close on October 22, 2026, Ryman Healthcare Ltd.'s stock has declined approximately 39.14% over the past 52 weeks. The 50-day moving average sits at 1.60, while the 200-day moving average is 1.92.

Over the twelve months ended March 31, 2025, Ryman Healthcare Ltd. generated 648.96M in revenue and converted that into -397.15M in net income, yielding earnings per share of -0.56. EBITDA reached -220.69M, while operating income came in at -107.51M.

As of March 31, 2025, Ryman Healthcare Ltd. holds 16.05M in cash and equivalents against 1.54B in total debt, resulting in a net debt position of 1.51B. Total book value stands at 3.87B, with working capital of -612.59M providing operational flexibility.

These figures cover the twelve months ended March 31, 2025.

These figures cover the twelve months ended March 31, 2025. The operating margin of -16.57 and net profit margin of -61.20 provide insight into operational efficiency.

Ryman Healthcare Ltd.'s most recent stock split took place on February 25, 2025.